We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.14%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.97B
AUM Growth
-$688M
(-10%)
Cap. Flow
-$778M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,150
New
217
Increased
235
Reduced
398
Closed
276
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$51.8M |
| 2 |
Visa
V
|
+$46.4M |
| 3 |
Comcast
CMCSA
|
+$45.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$36.3M |
| 5 |
Norfolk Southern
NSC
|
+$30.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$52.2M |
| 2 |
Starbucks
SBUX
|
+$51M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$41.7M |
| 4 |
Eli Lilly
LLY
|
+$40.3M |
| 5 |
Booking.com
BKNG
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.23% |
| 2 | Industrials | 13.43% |
| 3 | Financials | 12.16% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cardinal Health
CAH
$53.4B
| $11.6M | 0.2% |
166,360
+126,600
| +318% | +$8.8M |
|
152
O-I Glass
OI
$1.39B
| $11.4M | 0.19% |
336,950
+314,350
| +1,391% | +$10.5M |
|
|
XLS
153
DELISTED
EXELIS INC COM STK
XLS
| $11.4M | 0.19% |
641,115
+13,816
| +2% | +$255K |
|
|
CNW
154
DELISTED
CON-WAY INC.
CNW
| $11.4M | 0.19% |
276,556
-186,760
| -40% | -$7.35M |
|
155
Rockwell Automation
ROK
$51.4B
| $11.1M | 0.19% |
89,016
-58,758
| -40% | -$6.98M |
|
156
Pinnacle West Capital
PNW
$12.9B
| $11M | 0.19% |
202,144
-77,110
| -28% | -$4.13M |
|
157
Emcor
EME
$33.1B
| $11M | 0.18% |
234,883
-134,730
| -36% | -$5.93M |
|
|
SNI
158
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $10.8M | 0.18% |
142,371
-65,350
| -31% | -$5.09M |
|
|
EFII
159
DELISTED
Electronics for Imaging
EFII
| $10.7M | 0.18% |
248,031
-192,787
| -44% | -$8.13M |
|
160
Jacobs Solutions
J
$15.9B
| $10.7M | 0.18% |
204,212
+10,276
| +5% | +$529K |
|
|
HNT
161
DELISTED
HEALTH NET INC
HNT
| $10.7M | 0.18% |
315,176
-99,896
| -24% | -$3.28M |
|
162
Raymond James Financial
RJF
$32.5B
| $10.7M | 0.18% |
286,470
+78,090
| +37% | +$2.73M |
|
163
Artisan Partners
APAM
$2.79B
| $10.6M | 0.18% |
165,684
+86,554
| +109% | +$5.57M |
|
|
SAFM
164
DELISTED
Sanderson Farms Inc
SAFM
| $10.6M | 0.18% |
135,433
+77,180
| +132% | +$5.76M |
|
|
QLGC
165
DELISTED
QLOGIC CORP
QLGC
| $10.6M | 0.18% |
829,900
-15,500
| -2% | -$181K |
|
|
DCT
166
DELISTED
DCT Industrial Trust Inc.
DCT
| $10.6M | 0.18% |
335,643
+31,938
| +11% | +$960K |
|
|
PTP
167
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
| $10.5M | 0.18% |
174,400
-28,460
| -14% | -$1.66M |
|
|
AWH
168
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $10.4M | 0.17% |
302,658
-155,790
| -34% | -$5.35M |
|
|
MDP
169
DELISTED
Meredith Corporation
MDP
| $10.1M | 0.17% |
+218,121
| New | +$10M |
|
170
Nabors Industries
NBR
$1.23B
| $9.92M | 0.17% |
+8,050
| New | +$8.04M |
|
|
CAVM
171
DELISTED
Cavium, Inc.
CAVM
| $9.92M | 0.17% |
226,797
-132,396
| -37% | -$5.2M |
|
|
CODE
172
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $9.89M | 0.17% |
567,522
-22,800
| -4% | -$358K |
|
173
Children's Place
PLCE
$53.6M
| $9.83M | 0.16% |
197,330
-21,954
| -10% | -$1.17M |
|
174
Take-Two Interactive
TTWO
$43B
| $9.78M | 0.16% |
+445,970
| New | +$8.67M |
|
175
Nu Skin
NUS
$247M
| $9.64M | 0.16% |
116,406
-170,140
| -59% | -$14.9M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2014 Portfolio in Review
As of Q1 2014, Jacobs Levy Equity Management held 1,150 positions worth $5.97B, down 10% from $6.66B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management withdrew a net $778M in Q1 2014, closing 276 positions and reducing 398 holdings. Its most notable exit was Allergan Inc, an estimated $52.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bristol-Myers Squibb worth $35.5M.
- Jacobs Levy Equity Management's largest Q1 2014 buy was Bristol-Myers Squibb: 683,110 shares worth $35.5M.
- Jacobs Levy Equity Management added most to Amazon in Q1 2014, an estimated $51.8M increase.
- Jacobs Levy Equity Management's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $40.3M.
- Jacobs Levy Equity Management fully exited Allergan Inc in Q1 2014, selling an estimated $52.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.97B portfolio in Q1 2014.
- Jacobs Levy Equity Management opened 217 new positions and closed 276 in Q1 2014.
- Jacobs Levy Equity Management's portfolio value fell 10% quarter-over-quarter to $5.97B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.